63 related articles for article (PubMed ID: 8378389)
1. Cocaine causes a time dependent and dose dependent increase in D1 receptors and dopamine transporters.
Wamsley JR; Alburges ME
Proc West Pharmacol Soc; 1993; 36():277-82. PubMed ID: 8378389
[No Abstract] [Full Text] [Related]
2. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ
J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534
[TBL] [Abstract][Full Text] [Related]
3. Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding.
Koff JM; Shuster L; Miller LG
J Pharmacol Exp Ther; 1994 Jan; 268(1):277-82. PubMed ID: 8301568
[TBL] [Abstract][Full Text] [Related]
4. Relationship between subjective effects of cocaine and dopamine transporter occupancy.
Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE
Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740
[TBL] [Abstract][Full Text] [Related]
5. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters.
Daws LC; Callaghan PD; Morón JA; Kahlig KM; Shippenberg TS; Javitch JA; Galli A
Biochem Biophys Res Commun; 2002 Feb; 290(5):1545-50. PubMed ID: 11820798
[TBL] [Abstract][Full Text] [Related]
6. High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo.
Ghorai SK; Cook C; Davis M; Venkataraman SK; George C; Beardsley PM; Reith ME; Dutta AK
J Med Chem; 2003 Mar; 46(7):1220-8. PubMed ID: 12646032
[TBL] [Abstract][Full Text] [Related]
7. In vivo regulation of central nervous system progesterone receptors: cocaine induces steroid-dependent behavior through dopamine transporter modulation of D5 receptors in rats.
Apostolakis EM; Garai J; Clark JH; O'Malley BW
Mol Endocrinol; 1996 Dec; 10(12):1595-604. PubMed ID: 8961269
[TBL] [Abstract][Full Text] [Related]
8. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.
Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ
Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876
[TBL] [Abstract][Full Text] [Related]
9. L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism.
Volz TJ; Schenk JO
Synapse; 2004 Dec; 54(3):173-82. PubMed ID: 15452864
[TBL] [Abstract][Full Text] [Related]
10. Prenatal cocaine exposure affects postnatal dopaminergic systems in various regions of the rat brain.
Choi SJ; Mazzio E; Kolta MG; Soliman KF
Ann N Y Acad Sci; 1998 May; 844():293-302. PubMed ID: 9668686
[TBL] [Abstract][Full Text] [Related]
11. Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine.
Woolverton WL; Wang Z
Eur J Pharmacol; 2004 Feb; 486(3):251-7. PubMed ID: 14985046
[TBL] [Abstract][Full Text] [Related]
12. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transporters in the nucleus accumbens and the striatum have different apparent molecular weights.
Lew R; Vaughan R; Simantov R; Wilson A; Kuhar MJ
Synapse; 1991 Jun; 8(2):152-3. PubMed ID: 1882335
[No Abstract] [Full Text] [Related]
14. Effect of cocaine self-administration on striatal dopamine D1 receptors in rhesus monkeys.
Moore RJ; Vinsant SL; Nader MA; Porrino LJ; Friedman DP
Synapse; 1998 Jan; 28(1):1-9. PubMed ID: 9414012
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of cocaine: II. Mesocorticolimbic and striatal dopamine and cocaine receptors in C57BL and DBA mice.
Erwin VG; Womer DE; Campbell AD; Jones BC
Pharmacogenetics; 1993 Aug; 3(4):189-96. PubMed ID: 8220438
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo.
Tolliver BK; Newman AH; Katz JL; Ho LB; Fox LM; Hsu K; Berger SP
J Pharmacol Exp Ther; 1999 Apr; 289(1):110-22. PubMed ID: 10086994
[TBL] [Abstract][Full Text] [Related]
17. Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.
Villemagne VL; Rothman RB; Yokoi F; Rice KC; Matecka D; Dannals RF; Wong DF
Synapse; 1999 Apr; 32(1):44-50. PubMed ID: 10188637
[TBL] [Abstract][Full Text] [Related]
18. Studies of the mechanism of inhibition of the dopamine uptake carrier by cocaine in vitro using rotating disk electrode voltammetry.
McElvain JS; Schenk JO
Ann N Y Acad Sci; 1992 Jun; 654():480-2. PubMed ID: 1632608
[No Abstract] [Full Text] [Related]
19. Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens.
Nye HE; Hope BT; Kelz MB; Iadarola M; Nestler EJ
J Pharmacol Exp Ther; 1995 Dec; 275(3):1671-80. PubMed ID: 8531143
[TBL] [Abstract][Full Text] [Related]
20. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys.
Ginsburg BC; Kimmel HL; Carroll FI; Goodman MM; Howell LL
Pharmacol Biochem Behav; 2005 Mar; 80(3):481-91. PubMed ID: 15740791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
